Literature DB >> 15518707

Study of peroxisome proliferator-activated receptor (PPAR)-gamma in renal ischemia-reperfusion injury.

R Yoshimura1, M Matsuyama, Y Segawa, K Tsuchida, Y Takemoto, K Kuratsukuri, Y Kawahito, T Shinka, H Sano, T Nakatani.   

Abstract

Recent studies of ischemia-reperfusion (I/R) injury have focused on the function of neutrophils, the action mechanism of inflammatory cytokines. However, few reports have addressed peroxisome proliferator-activated receptor (PPAR)-gamma. PPAR-gamma is a ligand-activated transcriptional factor belonging to the steroid receptor superfamily. It plays a role in both adipocyte differentiation and tumorigenesis. We researched the expression of PPAR-gamma in renal I/R injury of the rat. Male Lewis rats were used. The right kidney was harvested and the left renal artery and vein were clamped at 90 minutes of ischemic time. Rats were killed at 0, 1.5, 3, 5, and 12 hours after reperfusion. PPAR-gamma expression was studied by immunohistostaining. PPAR-gamma expression was observed only on mesangial and endothelial cells of normal kidney. From 1.5 to 3 hours after reperfusion, PPAR-gamma expression gradually became stronger on mesangial and endothelial cells. PPAR-gamma expression was most intense on mesangial cells and endothelial cells at 3 hours after reperfusion. Twelve hours after reperfusion, necrosis extended throughout the ischemic kidney and nearly all the tubular epithelial cells were destroyed, but 12 hours after reperfusion PPAR-gamma expression gradually became weaker on mesangial and endothelial cells. PPAR-gamma was expressed in the rat model having renal I/R injury. Several hours after maximal of PPAR-gamma expression, maximal renal I/R injury was observed. These results may indicate a relationship between PPAR-gamma expression and renal I/R injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518707     DOI: 10.1016/j.transproceed.2004.08.039

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.

Authors:  Jorge E Toblli; Gabriel Cao; Jorge F Giani; Margarita Angerosa; Fernando P Dominici; Nestor F Gonzalez-Cadavid
Journal:  Kidney Blood Press Res       Date:  2010-11-11       Impact factor: 2.687

2.  Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.

Authors:  Qing Qing Wu; Yanxia Wang; Martin Senitko; Colin Meyer; W Christian Wigley; Deborah A Ferguson; Eric Grossman; Jianlin Chen; Xin J Zhou; John Hartono; Pamela Winterberg; Bo Chen; Anapam Agarwal; Christopher Y Lu
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

Review 3.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

4.  New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury.

Authors:  Miriam D Neher; Sebastian Weckbach; Markus S Huber-Lang; Philip F Stahel
Journal:  PPAR Res       Date:  2012-02-29       Impact factor: 4.964

5.  The Pro12Ala Polymorphism of PPAR-γ Gene Is Associated with Sepsis Disease Severity and Outcome in Chinese Han Population.

Authors:  Guoda Ma; Haiyang Wang; Guixi Mo; Lili Cui; You Li; Yiming Shao; Xin Liu; Yuliu Xie; Jia Li; Jiawu Fu; Hua Tao; Bin Zhao; Liangqing Zhang; Keshen Li
Journal:  PPAR Res       Date:  2014-07-20       Impact factor: 4.964

6.  Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ.

Authors:  Zhi-Hao Zhang; Jun-Qiu He; Ying-Yong Zhao; Hua-Chao Chen; Ning-Hua Tan
Journal:  Acta Pharmacol Sin       Date:  2019-11-08       Impact factor: 6.150

7.  Protective Actions of PPAR-gamma Activation in Renal Endothelium.

Authors:  Peter E Westerweel; Marianne C Verhaar
Journal:  PPAR Res       Date:  2009-02-26       Impact factor: 4.964

8.  Cilostazol renoprotective effect: modulation of PPAR-γ, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusion.

Authors:  Diaa Ragab; Dalaal M Abdallah; Hanan S El-Abhar
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.